In the latest quarter, 10 analysts provided ratings for P10 PX, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 5 | 5 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 3 | 0 | 0 |
3M Ago | 0 | 1 | 2 | 0 | 0 |
Analysts have recently evaluated P10 and provided 12-month price targets. The average target is $14.4, accompanied by a high estimate of $21.00 and a low estimate of $12.00. Surpassing the previous average price target of $12.60, the current average has increased by 14.29%.
Exploring Analyst Ratings: An In-Depth Overview
The standing of P10 among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Kenneth Worthington | JP Morgan | Raises | Overweight | $15.00 | $14.00 |
Chris Kotowski | Oppenheimer | Raises | Outperform | $21.00 | $17.00 |
Benjamin Budish | Barclays | Raises | Overweight | $15.00 | $14.00 |
Kenneth Worthington | JP Morgan | Raises | Neutral | $14.00 | $11.00 |
John Campbell | Stephens & Co. | Raises | Overweight | $13.00 | $12.00 |
Michael Cyprys | Morgan Stanley | Raises | Equal-Weight | $13.00 | $12.00 |
Kyle Voigt | Keefe, Bruyette & Woods | Raises | Market Perform | $13.00 | $12.50 |
Adam Beatty | UBS | Raises | Neutral | $12.00 | $10.50 |
Chris Kotowski | Oppenheimer | Raises | Outperform | $16.00 | $13.00 |
Michael Cyprys | Morgan Stanley | Raises | Equal-Weight | $12.00 | $10.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to P10. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of P10 compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of P10's stock. This comparison reveals trends in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of P10's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on P10 analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Discovering P10: A Closer Look
P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
A Deep Dive into P10's Financials
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: P10's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 25.96%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: P10's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.89%, the company may face hurdles in effective cost management.
Return on Equity (ROE): P10's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.4%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): P10's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.17%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: P10's debt-to-equity ratio is below the industry average. With a ratio of 0.96, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: What Are They?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.